Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) [Phase 2]
Phase 2 study UNICAB evaluating cabozantinib in various non-clear cell renal cell carcinoma subtypes after immunotherapy has been completed.
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Prospective Evaluation of AI R&D Tool for Patient Stratification: a Trial for Renal Immuno-oncology Model Experimental Evaluation 2
A prospective evaluation of an AI-based patient stratification tool for renal immuno-oncology in metastatic renal cell carcinoma has been te…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC) [NA]
A completed clinical trial evaluating serial ultrasound in metastatic renal cell carcinoma has posted results as of July 25, 2025.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
NuCana plc announced termination of a Phase 1/2 trial evaluating NUC-3373 in combination with other agents for patients with advanced solid …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India [Phase 4]
Phase 4 study evaluating the safety and efficacy of nivolumab plus ipilimumab in untreated advanced renal cell carcinoma completed in India,…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy
Real-world study assessing effectiveness and safety of first-line nivolumab plus ipilimumab versus nivolumab monotherapy (after prior therap…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 study evaluating front-line nivolumab therapy with salvage nivolumab plus ipilimumab in patients with advanced renal cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) [Phase 1]
Phase 1 trial update of belzutifan (PT2977, MK-6482) in patients with advanced solid tumors; study status is Phase 1 and not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors [Phase 1]
This Phase 1 trial assesses Autogene Cevumeran (RO7198457) as a single agent and in combination with atezolizumab across multiple locally ad…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Open vs Robotic Assisted Partial Nephrectomy [NA]
The clinical trial comparing open versus robotic-assisted partial nephrectomy for renal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of CDX-585 in Patients With Advanced Malignancies [Phase 1]
Phase 1 trial update showing completed enrollment and results for CDX-585 in patients with advanced solid tumors, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery [Phase 3]
Phase 3 trial comparing hippocampus-sparing whole-brain radiotherapy to stereotactic radiosurgery for patients with brain metastases from va…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR) [Phase 2]
Phase 2 study evaluating nivolumab as pre- and post-operative therapy for metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial of nivolumab in combination with ipilimumab for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies [Phase 1]
A Phase Ib safety study of Selinexor (KPT-330) in combination with standard chemotherapy or immunotherapy agents for patients with advanced …
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the combination of talazoparib and axitinib for previously treated advanced renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer [Phase 1]
Phase 1 study evaluating the safety of combining radiation therapy with pembrolizumab (MK-3475) in patients with recurrent/metastatic head a…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors [NA]
This completed clinical trial evaluated pentafecta outcomes in open and laparoscopic partial nephrectomy for localized renal tumors.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT
A completed clinical trial evaluating the use of FPIA PET/CT to measure treatment response in metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005) [Phase 3]
Phase 3 trial comparing belzutifan to everolimus in advanced renal cell carcinoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC) [Phase 1]
Phase 1 study evaluating the combination of lenvatinib and everolimus in renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors [Phase 1]
Phase 1 study of TBio-6517 alone or in combination with pembrolizumab in solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Clinical Study of 18F -FAPI-RGD in Renal Tumor
The clinical study evaluating the imaging tracer 18F-FAPI-RGD for renal cell carcinoma has completed.